| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
BASIC SCIENCE |




,
*Department of Human Genetics, McGill University, Montreal, Quebec, Canada;
Department of Paediatrics, Montreal Childrens Hospital, McGill University, Montreal, Quebec, Canada;
Department of Pathology, University of Otago, Dunedin, New Zealand;
Centre for Research in Neuroscience, Montreal General Hospital, McGill University, Montreal, Quebec, Canada; and ¶Department of Biochemistry, McGill University, Quebec, Canada.
Correspondence to Dr. Michael Eccles, Department of Pathology, University of Otago, Dunedin 9015, New Zealand. Phone: +64-3479-7878; Fax: +64-3479 7139;
ABSTRACT. In humans, PAX2 haploinsufficiency causes renal-coloboma syndrome (RCS) involving eye abnormalities, renal hypoplasia, and renal failure in early life. The authors previously showed that heterozygous mutant Pax2 mice have smaller kidneys with fewer nephrons, associated with elevated apoptosis in the ureteric bud (UB). However, PAX2 may have a variety of developmental functions such as effects on cell fate and differentiation. To determine whether apoptosis alone is sufficient to cause a UB branching deficit, the authors targeted a pro-apoptotic gene (Bax
) to the embryonic kidney under the control of human PAX2 regulatory elements. The exogenous PAX2 promoter directed Bax
gene expression specifically to the developing kidney UB, eye, and mid/hindbrain. At E15.5 PAX2Promoter-Bax
fetal mice exhibited renal hypoplasia, elevated UB apoptosis, and retinal defects, mimicking the phenotype observed in RCS. The kidneys of E15.5 PAX2Promoter-Bax
fetal mice were 55% smaller than those of wild-type fetal mice, and they contained 70% of the normal level of UB branching. The data indicate that loss of Pax2 anti-apoptotic activity is sufficient to account for the reduced UB branching observed in RCS and suggest that elevated UB apoptosis may be a key process responsible for renal hypoplasia. The authors propose a morphogenic unit model in which cell survival influences the rate of UB branching and determines final nephron endowment. E-mail: meccles@otago.ac.nz
This article has been cited by other articles:
![]() |
S. Hartwig, D. Bridgewater, V. Di Giovanni, J. Cain, Y. Mishina, and N. D. Rosenblum BMP Receptor ALK3 Controls Collecting System Development J. Am. Soc. Nephrol., January 1, 2008; 19(1): 117 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Zhang, Y.-W. Chen, S. Tran, I. Chenier, M.-J. Hebert, and J. R. Ingelfinger Reactive Oxygen Species in the Presence of High Glucose Alter Ureteric Bud Morphogenesis J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2105 - 2115. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cohen, O. Loutochin, M. Amin, J.-P. Capolicchio, P. Goodyer, and R. Jednak PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1267 - F1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stayner, D. M. Iglesias, P. R. Goodyer, L. Ellis, G. Germino, J. Zhou, and M. R. Eccles Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease Hum. Mol. Genet., December 15, 2006; 15(24): 3520 - 3528. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Park, H. Jia, V. Rajakumar, and H. M. Chamberlin Pax2/5/8 proteins promote cell survival in C. elegans Development, November 1, 2006; 133(21): 4193 - 4202. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dziarmaga, P.-A. Hueber, D. Iglesias, N. Hache, A. Jeffs, N. Gendron, A. MacKenzie, M. Eccles, and P. Goodyer Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2 Am J Physiol Renal Physiol, October 1, 2006; 291(4): F913 - F920. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dziarmaga, M. Eccles, and P. Goodyer Suppression of Ureteric Bud Apoptosis Rescues Nephron Endowment and Adult Renal Function in Pax2 Mutant Mice J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1568 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Torban, A. Dziarmaga, D. Iglesias, L. L. Chu, T. Vassilieva, M. Little, M. Eccles, M. Discenza, J. Pelletier, and P. Goodyer PAX2 Activates WNT4 Expression during Mammalian Kidney Development J. Biol. Chem., May 5, 2006; 281(18): 12705 - 12712. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cai, N. I. Dmitrieva, J. D. Ferraris, H. L. Brooks, B. W. M. van Balkom, and M. Burg Pax2 expression occurs in renal medullary epithelial cells in vivo and in cell culture, is osmoregulated, and promotes osmotic tolerance PNAS, January 11, 2005; 102(2): 503 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Clark, A. Dziarmaga, M. Eccles, and P. Goodyer Rescue of Defective Branching Nephrogenesis in Renal-Coloboma Syndrome by the Caspase Inhibitor, Z-VAD-fmk J. Am. Soc. Nephrol., February 1, 2004; 15(2): 299 - 305. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673